共 30 条
[2]
[3]
Basaria S, 2011, J CACHEXIA SARCOPENI, V2, P209
[4]
Bogomolovas J, 2011, J CACHEXIA SARCOPENI, V2, P209
[5]
Bonetto A, 2011, J CACHEXIA SARCOPENI, V2, P209
[6]
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
[J].
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE,
2011, 2 (04)
:201-207
[8]
Dodson S, 2011, J CACHEXIA SARCOPENI, V2, P209
[9]
Elkina Y, 2012, J CACHEXIA SARCOPENI, V3, P7
[10]

